Potential for cost economies in guiding therapy in patients with metastatic breast cancer.

[1]  N. Naqos.  Advanced Breast Cancer , 1977, The Lancet.

[2]  A. Howell,et al.  Objective measurement of therapeutic response in breast cancer using tumour markers. , 1991, British Journal of Cancer.

[3]  W. Gregory,et al.  Advanced breast cancer: use of resources and cost implications. , 1993, British Journal of Cancer.

[4]  A. Hancock,et al.  An evaluation of mucin-like carcinoma associated antigen (MCA) in breast cancer. , 1989, British Journal of Cancer.

[5]  R. K. Knight,et al.  Chemotherapy of advanced breast cancer: outcome and prognostic factors. , 1993, British Journal of Cancer.

[6]  M. Williams,et al.  An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data. , 1990, British Journal of Cancer.

[7]  A. Dnistrian,et al.  CA 15-3 and carcinoembryonic antigen in the clinical evaluation of breast cancer. , 1991, Clinica chimica acta; international journal of clinical chemistry.

[8]  A. Howell,et al.  Assessment of four monoclonal antibodies as serum markers in breast cancer. , 1990, European journal of cancer.

[9]  R. Rubens,et al.  Assessment of response to therapy in advanced breast cancer. , 1977, British Journal of Cancer.

[10]  R. Gelman,et al.  Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer. , 1988, Cancer research.

[11]  R. Bast,et al.  Comparison of a novel assay for breast cancer mucin to CA15-3 and carcinoembryonic antigen. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  S. Hurley,et al.  The cost of breast cancer recurrences. , 1992, British Journal of Cancer.

[13]  M. Williams,et al.  Factors predicting the response of patients with advanced breast cancer to endocrine (Megace) therapy. , 1989, European journal of cancer & clinical oncology.

[14]  H. D. de Koning,et al.  Advanced breast cancer and its prevention by screening. , 1992, British Journal of Cancer.

[15]  A. Otterland.  [ON MORTALITY STATISTICS]. , 1964, Social-Medicinsk tidskrift.